{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Is BioAtla, Inc. technically bullish or bearish?
As of May 5, 2025, BioAtla, Inc. is in a mildly bearish trend, driven by daily moving averages and mixed monthly indicators, despite some mildly bullish signals from the weekly MACD and KST.
What does BioAtla, Inc. do?
BioAtla, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net loss of $15 million and a market cap of $22.78 million. It has no P/E ratio due to losses, a dividend yield of 0.00%, and a highly negative return on equity of -6,456.30%.
How big is BioAtla, Inc.?
As of Jun 18, BioAtla, Inc. has a market capitalization of 22.78 million, with net sales of 11.00 million and a net profit of -61.87 million over the last four quarters. Shareholder's funds are 14.27 million, and total assets are 52.42 million as of Dec 24.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
